Market Research Reprots- Worldwide In Situ Hybridization Market

In Situ Hybridization Market Worth $7.8
billion by 2024
The global market for In Situ Hybridization (ISH) at $4.3 billion in 2017 is anticipated to reach
$7.8 billion by 2024. Worldwide markets are poised to achieve continuing growth as In Situ
Hybridization is used in diagnostic situations to analyze single cells inside tissue. Managing
single cell diagnostics in real time, encouraging collaborative business efforts. Lowering
transaction management costs is a key benefit.
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA,
RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence
in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds,
Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor
cells (CTCs).